Asia Pacific Eubiotics Market Size & Outlook, 2022-2030

The eubiotics market in Asia Pacific is expected to reach a projected revenue of US$ 1,990.3 million by 2030. A compound annual growth rate of 7.2% is expected of Asia Pacific eubiotics market from 2023 to 2030.
Revenue, 2022 (US$M)
$1,144.2
Forecast, 2030 (US$M)
$1,990.3
CAGR, 2023 - 2030
7.2%
Report Coverage
Asia Pacific

Asia Pacific eubiotics market highlights

  • The Asia Pacific eubiotics market generated a revenue of USD 1,144.2 million in 2022.
  • The market is expected to grow at a CAGR of 7.2% from 2023 to 2030.
  • In terms of segment, probiotics was the largest revenue generating product in 2022.
  • Probiotics is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Japan is expected to register the highest CAGR from 2023 to 2030.


Asia Pacific data book summary

Market revenue in 2022USD 1,144.2 million
Market revenue in 2030USD 1,990.3 million
Growth rate7.2% (CAGR from 2022 to 2030)
Largest segmentProbiotics
Fastest growing segmentProbiotics
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationProbiotics, Prebiotics, Organic Acids, Phtyogenics
Key market players worldwideDSM Firmenich AG, Mitsui & Co Ltd, Lallemand, Beneo, Kemin Industries, DuPont de Nemours Inc, Novonesis AS ADR, Associated British Foods PLC, Novozymes, Evonik Industries AG, Basf SE, Cargill, Archer-Daniels Midland Co, China National Bluestar Group


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 23.3% of the global eubiotics market in 2022.
  • Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
  • North America is the fastest growing regional market and is projected to reach USD 2,654.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Eubiotics Market Companies

Name Profile # Employees HQ Website

Asia Pacific eubiotics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to eubiotics market will help companies and investors design strategic landscapes.


Probiotics was the largest segment with a revenue share of 41.47% in 2022. Horizon Databook has segmented the Asia Pacific eubiotics market based on probiotics, prebiotics, organic acids, phtyogenics covering the revenue growth of each sub-segment from 2018 to 2030.


The market growth can be attributed to the increased consumer spending, growing consumption of animal products, and flourishing animal feed industry. Increasing production and exports of feed additives in the region from key countries such as China and Japan is anticipated to contribute to the market growth.

Growing consumption of meat and meat products in the region has generated a need to focus on animal health and hygiene, which, in turn, has given rise to the demand for feed additives.

Thus, rise in the demand for feed additives is likely to boost the growth of zinc methionine chelates market in the region. Rising pork and beef consumption in China, Japan, South Korea, and India is one of the major factors driving the demand for animal feed and feed additives in the region.

Reasons to subscribe to Asia Pacific eubiotics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific eubiotics market databook

  • Our clientele includes a mix of eubiotics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific eubiotics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific eubiotics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific eubiotics market size, by country, 2018-2030 (US$M)

Asia Pacific Eubiotics Market Outlook Share, 2022 & 2030 (US$M)

Asia Pacific eubiotics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more